| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |